U.S. flag An official website of the United States government
  1. Home
  2. For Federal, State, Local, Tribal, and Territorial Officials
  3. Communications & Outreach
  4. News & Events
  5. FDA Sample Collection Criteria and Information for Vaping Related Incidents
  1. News & Events

FDA Sample Collection Criteria and Information for Vaping Related Incidents

CDC and FDA Product Sample Submission Information

CDC and FDA are working together to coordinate analysis of vaping products, including e-cigarettes, to provide insight into the nature of the chemical exposure(s) contributing to the Lung Injury outbreak. FDA is analyzing e-liquids for the presence of a broad range of chemicals. When sufficient liquid product is available, CDC will conduct aerosol emissions testing of the e-cigarette or other vaping product. The graphic below outlines the process for states to submit product samples to FDA and CDC for testing.

Analysis of both e-liquid and aerosol emissions will complement each other, and together will help improve our understanding of exposure among case patients associated with the Lung Injury outbreak.

This graphic outlines how states can submit product samples for testing at CDC and FDA for the lung injury response.
This graphic outlines how states can submit product samples for testing at CDC and FDA for the lung injury response. In the first box to the left, a clipboard with a checkmark is shown to help illustrate the first step in the process. In this step, states collect product and link it with a CDC case ID. An arrow then leads users to the next box to the right to show the next step in the process, which is illustrated by an image of a computer receiving an email. In this step, states can request to submit product to either CDC or FDA. Product(s) must be linked to a confirmed or probable case and have a CDC case ID. An arrow then leads users to the next box to the right showing the third step, illustrated by a two people on a phone call speaking with each other. In this step, points of contact will review sample submissions using agreed upon criteria (e.g., volume of sample). These points of contact will then work with the state on next steps. From here, the graphic points to two different boxes, depending on how the sample is triaged. The top box shows the situation in which the product sample contains sufficient volume and CDC will conduct aerosol testing on it. This box is illustrated with an e-cigarette, or vaping product, with an arrow to CDC. CDC will then send remaining sample to FDA for e-liquid testing. The bottom box in this step shows e-liquid testing at FDA. It is illustrated with an e-cigarette, or vaping, product with an arrow to FDA. The last step is shown in the box to the right. It is illustrated by computers linking with the cloud. In this step, agencies report data to the states. Additionally, both CDC and FDA will enter data from their testing in a secure repository to link epidemiologic, clinical, and product sample information to cases.

States can request to submit product to either CDC or FDA. Product(s) must be linked to a confirmed or probable case and have a CDC case ID.  

  • For information about collection and submission of e-cigarette or other vaping products, including e-liquids, associated with confirmed or probable cases for possible testing by FDA, contact: FDAVapingSampleInquiries@fda.hhs.gov.
  • For information about collection and submission of e-cigarette or other vaping products’ e-liquids associated with confirmed or probable cases for possible aerosol emissions testing by CDC, contact IncidentResponse@cdc.gov.